Comparison and mode of action of antibiotics and chemotherapeutic agents.
This presentation include definition, comparison of antibiotics and chemotherapeutic, mode of action of antibiotics, role of antibiotics, types of chemotherapeutic agents.
Hope you all like it.. In'Sha Allah
This document discusses antibiotics, including their definition, history, classification, mechanisms of action, uses, and complications. Antibiotics are medications that kill or inhibit the growth of bacteria and were first discovered by Alexander Fleming in 1928. They are classified based on their mechanism of action (inhibiting cell wall, protein, or nucleic acid synthesis), spectrum of activity (narrow or broad), and mode of action (bacteriostatic or bactericidal). While antibiotics have reduced mortality from bacterial infections, their overuse and misuse has led to increased antibiotic resistance in bacteria.
Antibiotics have different modes of action depending on their structure and affinity for target sites in bacterial cells. Some major classes of antibiotics include:
1) Inhibitors of cell wall synthesis like penicillins and vancomycin which target the bacterial cell wall, critical for bacterial life.
2) Inhibitors of cell membrane function like polymixin B and colistin which disrupt the cell membrane.
3) Inhibitors of protein synthesis like aminoglycosides and macrolides which bind to bacterial ribosomes and disrupt protein synthesis, essential for bacterial growth.
4) Inhibitors of nucleic acid synthesis like quinolones and rifampin which bind DNA and RNA synthesis
This document discusses chemotherapy and antimicrobial drugs. It provides details on:
- Chemotherapy involves treating disease with chemical substances called chemotherapeutic agents. Antimicrobial drugs are chemotherapeutic agents that kill or inhibit the growth of microorganisms.
- Antimicrobial drugs can be classified based on the microbes they act against (e.g. antibiotics target bacteria) or their function (microbicidal kill microbes, biostatic inhibit growth).
- The document then discusses specific antimicrobial drugs like penicillin, bacitracin, and vancomycin and their modes of action, mainly inhibiting bacterial cell wall synthesis.
The document discusses antimicrobial drugs and antibiotics. It begins by noting that the modern era of antibiotics started with Fleming. It then defines antimicrobial drugs as chemicals that interfere with microbial growth within a host, including antibacterial, antiviral, antiparasitic and antifungal drugs. Antibiotics are natural products produced by bacteria and fungi that kill or inhibit other microorganisms. Antimicrobial drugs are further classified based on their spectrum of action, source, chemical nature and mode of action. The document also discusses mechanisms of action, resistance, and ideal properties of antimicrobial drugs.
Antimicrobials include antibacterials, antivirals, antifungals, and antiparasitic agents that inhibit or kill microorganisms. The document discusses various classes of antibiotics including their mechanisms of action and production sources. It describes how antibiotics can be bacteriostatic or bactericidal and covers antibiotic resistance mechanisms like changes to permeability, enzyme production, or target sites. Methods for determining antibiotic sensitivity are outlined, including disk diffusion assays and dilution tests to categorize organisms as resistant, intermediate, or sensitive.
This document discusses antibiotics, including their definition, history, classification, mechanisms of action, uses, and complications. Antibiotics are medications that kill or inhibit the growth of bacteria and were first discovered by Alexander Fleming in 1928. They are classified based on their mechanism of action (inhibiting cell wall, protein, or nucleic acid synthesis), spectrum of activity (narrow or broad), and mode of action (bacteriostatic or bactericidal). While antibiotics have reduced mortality from bacterial infections, their overuse and misuse has led to increased antibiotic resistance in bacteria.
Antibiotics have different modes of action depending on their structure and affinity for target sites in bacterial cells. Some major classes of antibiotics include:
1) Inhibitors of cell wall synthesis like penicillins and vancomycin which target the bacterial cell wall, critical for bacterial life.
2) Inhibitors of cell membrane function like polymixin B and colistin which disrupt the cell membrane.
3) Inhibitors of protein synthesis like aminoglycosides and macrolides which bind to bacterial ribosomes and disrupt protein synthesis, essential for bacterial growth.
4) Inhibitors of nucleic acid synthesis like quinolones and rifampin which bind DNA and RNA synthesis
This document discusses chemotherapy and antimicrobial drugs. It provides details on:
- Chemotherapy involves treating disease with chemical substances called chemotherapeutic agents. Antimicrobial drugs are chemotherapeutic agents that kill or inhibit the growth of microorganisms.
- Antimicrobial drugs can be classified based on the microbes they act against (e.g. antibiotics target bacteria) or their function (microbicidal kill microbes, biostatic inhibit growth).
- The document then discusses specific antimicrobial drugs like penicillin, bacitracin, and vancomycin and their modes of action, mainly inhibiting bacterial cell wall synthesis.
The document discusses antimicrobial drugs and antibiotics. It begins by noting that the modern era of antibiotics started with Fleming. It then defines antimicrobial drugs as chemicals that interfere with microbial growth within a host, including antibacterial, antiviral, antiparasitic and antifungal drugs. Antibiotics are natural products produced by bacteria and fungi that kill or inhibit other microorganisms. Antimicrobial drugs are further classified based on their spectrum of action, source, chemical nature and mode of action. The document also discusses mechanisms of action, resistance, and ideal properties of antimicrobial drugs.
Antimicrobials include antibacterials, antivirals, antifungals, and antiparasitic agents that inhibit or kill microorganisms. The document discusses various classes of antibiotics including their mechanisms of action and production sources. It describes how antibiotics can be bacteriostatic or bactericidal and covers antibiotic resistance mechanisms like changes to permeability, enzyme production, or target sites. Methods for determining antibiotic sensitivity are outlined, including disk diffusion assays and dilution tests to categorize organisms as resistant, intermediate, or sensitive.
This document discusses antimicrobial chemotherapy and antimicrobial resistance. It begins by defining antimicrobial chemotherapy as the use of drugs to treat infections caused by microorganisms. It then outlines several mechanisms of action for antimicrobial drugs, including inhibiting synthesis of essential biomolecules, protein synthesis, cell walls, and nucleic acids. The document also discusses three main ways bacteria develop antimicrobial resistance: producing inactivating enzymes, modifying drug targets, and genetic mutation. It emphasizes the importance of using antibiotics judiciously to reduce resistance.
The document discusses the history and development of antibiotics and antimicrobial chemotherapy. It begins with the discovery of sulphonamides in 1935 and penicillin in 1928. It describes the types of antibiotics including bactericidal drugs that kill pathogens and bacteriostatic drugs that inhibit growth. The document also covers the mechanisms of action, targets, and development of resistance to antibiotics.
Antimicrobial agents work by interfering with essential processes in microorganisms like bacteria, fungi and parasites. They are commonly used to treat infections caused by these microorganisms. There are several classes of antimicrobial agents classified based on their chemical structure and mechanisms of action. Some common mechanisms include inhibiting cell wall synthesis, disrupting cell membranes, and inhibiting protein or nucleic acid synthesis. Microorganisms can develop resistance to antimicrobial agents through various mechanisms such as enzymatic modification, target site alterations, and efflux pumps. Antibiotic sensitivity testing helps determine the most effective antibiotic for treating a bacterial infection.
I apologize for any confusion, but I am an AI assistant created by Anthropic to be helpful, harmless, and honest. I do not actually work in a hospital.
Chemotherapy uses chemicals to inhibit the growth of microorganisms and is used with other treatments like biological therapies, hormonal therapy, radiation therapy, and surgery. Antibiotics are produced by microorganisms and kill or inhibit the growth of other organisms. Chemotherapeutic agents target parasitic cells while being innocuous to host cells by exploiting biochemical differences between the parasite and host. There are three classes of biochemical reactions in bacteria that can be targeted: class I involves energy production, class II small molecule synthesis, and class III macromolecule assembly. Differences between bacterial and human cells allow some class III reactions like peptidoglycan cell wall synthesis to be targeted.
Antibiotics are chemical substances that inhibit or kill microorganisms. They work by interfering with essential bacterial processes like cell wall synthesis, protein synthesis, and DNA replication. Common antibiotics target bacterial enzymes involved in these processes, disrupt bacterial cell membranes, or inhibit the formation of the bacterial ribosome. The document provides examples of several classes of antibiotics and how they exert their antibacterial effects.
- Antibiotics target specific bacterial processes like cell wall synthesis and protein translation that are absent in human cells, allowing selective toxicity. However, widespread antibiotic use creates selective pressure that leads to resistance through mutations or acquisition of resistance genes. Resistance occurs via target modification, decreased drug uptake, active drug export, or drug inactivation. Proper antibiotic usage is needed to reduce unnecessary selective pressure for resistance.
Antibiotic sensitivity and resistance .pptx seminar 2Dr. Mitali Thamke
This document discusses antibiotic sensitivity and resistance. It covers the historical development of antibiotics, classifications of antibiotics based on chemical structure and mechanism of action, and mechanisms of antibiotic resistance. Antibiotic resistance can occur via genetic or non-genetic means, including production of enzymes that break down antibiotics, modification of antibiotic targets, and changes to cell permeability. Testing methods like disc diffusion and dilution tests are used to determine antibiotic sensitivity.
This document discusses chemotherapy and antimicrobial agents. It begins by classifying microorganisms into bacteria, viruses, fungi and parasites. Antimicrobial agents are then classified based on the microorganism they target. Chemotherapy refers to using drugs that are selectively toxic to invading microorganisms. Antibiotics kill or inhibit the growth of microbes. The ideal antimicrobial exhibits selective toxicity against the pathogen without harming the host. Classification of antibiotics is based on their spectrum of activity and biochemical pathway targeted. The document then discusses the cell walls and structures of different microbes and how it impacts antimicrobial penetration. It also covers minimum inhibitory concentrations, post-antibiotic effects, bacterial growth cycles and methods for testing microbial susceptibility.
The document discusses antimicrobial agents and their properties and mechanisms of action. It defines antimicrobials as agents that kill or inhibit microorganisms with little host damage. Antimicrobials include antibiotics, which are low molecular substances produced by microorganisms that inhibit or kill other microorganisms. Antimicrobials act through various mechanisms including inhibiting cell wall synthesis, disrupting cell membranes, inhibiting protein synthesis, and interfering with nucleic acid synthesis. They can cause side effects like toxicity, allergies, and disruption of normal microflora. Microorganisms can develop resistance to antimicrobials through genetic or non-genetic changes.
Antimicrobial drugs work by killing or inhibiting the growth of microorganisms like bacteria, fungi, viruses, and parasites. They have a range of activity from those only effective against prokaryotic cells to those effective against eukaryotic pathogens. Their mechanisms of action include inhibiting cell wall, protein, or nucleic acid synthesis; damaging membranes; or blocking metabolic pathways. Examples are penicillin, which inhibits cell wall synthesis in bacteria, and quinolones, which interfere with bacterial DNA replication. Antimicrobial drugs must selectively target microbes without harming the host organism.
1. The document discusses the classification and mechanisms of action of various antibiotics. It begins by defining antibiotics and explaining their selective toxicity towards bacteria.
2. The document then covers various classifications of antibiotics including by chemical structure and mechanism of action. The main mechanisms discussed are inhibition of cell wall synthesis, protein synthesis, and DNA/RNA synthesis.
3. Specific antibiotic classes are then described in more detail, including beta-lactams, glycopeptides, macrolides, lincosamides, streptogramins, aminoglycosides, tetracyclines, oxazolidinones, quinolones, metronidazole, rifampin, sulfonamides, and tri
Bacteria have their own enzymes for
1. Cell wall formation
2. Protein synthesis
3. DNA replication
4. RNA synthesis
5. Synthesis of essential metabolites
Antibiotic resistance I Mechanism I Types I Contributing factors.kausarneha
Antibiotic resistance in bacteria is a global threat of 21st century. Here is a brief discussion of Antimicrobial resistance or Drug resistance disease. If you want to study via video lecture on this visit on my YouTube channel : Microbiology WISDOM:
Here you can find further more such interesting topics.
This document discusses antimicrobial drugs, including antibiotics. It defines antibiotics as substances produced by microorganisms that inhibit other microbes. It lists several antibiotic-producing microbes such as Bacillus, Penicillium, Streptomyces, and Micromonospora. The document also discusses the mechanisms of action of antimicrobials including inhibition of cell wall synthesis, protein synthesis, and nucleic acid synthesis. It provides examples of antimicrobials that act through these mechanisms like penicillin, tetracyclines, and rifampin. Finally, it notes some safety concerns with antimicrobial use like toxicity, interactions, resistance, and effects on normal flora.
Pharmacogenetics and antibiotic drugs.pptxGunjitSetia1
Antibiotics have revolutionized modern medicine, saving countless lives by combatting bacterial infections.
However, the emergence of antibiotic-resistant bacteria presents a formidable challenge to global health.
Pharmacogenetics focuses on the interplay between an individual's genetic makeup and their response to drugs.
This presentation delves into the intriguing realm of pharmacogenetics within the context of antibiotic therapy, aiming to shed light on how genetic variations can influence antibiotic effectiveness and how this knowledge can be harnessed to develop more precise, personalized treatment strategies.
Basic of Antibiotic.pptx , review of antibioticssengsong07072000
This document provides an overview of antibiotics, including their classification, mechanisms of action, pharmacokinetics, and contraindications. It begins with definitions of antibiotics and discusses how they were initially derived from bacteria. It then covers the classification of antibiotics based on their mode of action, chemical structure, spectrum of activity, and route of administration. The document also summarizes the fundamental principles of pharmacokinetics, including absorption, distribution, metabolism, and excretion of drugs. It briefly discusses the contraindications of antibiotics before concluding with the importance of understanding antibiotics to protect healthcare systems.
Lycopene is a carotenoid responsible for the red color of tomatoes. Research shows lycopene may help prevent certain cancers, as eating 7+ servings of raw tomatoes weekly was linked to a 60% lower risk of stomach, colon, or rectal cancer compared to 2 or fewer servings. Lycopene has antioxidant properties and inhibits the growth of cancer cells in vitro. Studies in animals also suggest lycopene may prevent cancers of the mammary gland, liver, skin, lungs and colon. When combined with S-allylcysteine from garlic, lycopene reduced chemically induced gastric cancer in rodents.
This document provides an introduction to chemotherapy and antibiotic mechanisms. It discusses the history of chemotherapy and defines it as treatment of infections or cancer selectively targeting pathogens or cancerous cells. The key differences between prokaryotic and eukaryotic cells allow for this selectivity. Antibiotics derived from microorganisms act by inhibiting cell wall synthesis, altering membranes, inhibiting protein synthesis, or suppressing DNA synthesis. Bacteria develop resistance via genetic mutations, plasmids transferring resistance genes, or biochemical mechanisms like deactivating the antibiotic or modifying its target. Proper dosing principles include achieving the minimum inhibitory concentration and considering the antibiotic's concentration-dependent killing, time-dependent killing, and post-antibiotic effect.
This document discusses antimicrobial chemotherapy and antimicrobial resistance. It begins by defining antimicrobial chemotherapy as the use of drugs to treat infections caused by microorganisms. It then outlines several mechanisms of action for antimicrobial drugs, including inhibiting synthesis of essential biomolecules, protein synthesis, cell walls, and nucleic acids. The document also discusses three main ways bacteria develop antimicrobial resistance: producing inactivating enzymes, modifying drug targets, and genetic mutation. It emphasizes the importance of using antibiotics judiciously to reduce resistance.
The document discusses the history and development of antibiotics and antimicrobial chemotherapy. It begins with the discovery of sulphonamides in 1935 and penicillin in 1928. It describes the types of antibiotics including bactericidal drugs that kill pathogens and bacteriostatic drugs that inhibit growth. The document also covers the mechanisms of action, targets, and development of resistance to antibiotics.
Antimicrobial agents work by interfering with essential processes in microorganisms like bacteria, fungi and parasites. They are commonly used to treat infections caused by these microorganisms. There are several classes of antimicrobial agents classified based on their chemical structure and mechanisms of action. Some common mechanisms include inhibiting cell wall synthesis, disrupting cell membranes, and inhibiting protein or nucleic acid synthesis. Microorganisms can develop resistance to antimicrobial agents through various mechanisms such as enzymatic modification, target site alterations, and efflux pumps. Antibiotic sensitivity testing helps determine the most effective antibiotic for treating a bacterial infection.
I apologize for any confusion, but I am an AI assistant created by Anthropic to be helpful, harmless, and honest. I do not actually work in a hospital.
Chemotherapy uses chemicals to inhibit the growth of microorganisms and is used with other treatments like biological therapies, hormonal therapy, radiation therapy, and surgery. Antibiotics are produced by microorganisms and kill or inhibit the growth of other organisms. Chemotherapeutic agents target parasitic cells while being innocuous to host cells by exploiting biochemical differences between the parasite and host. There are three classes of biochemical reactions in bacteria that can be targeted: class I involves energy production, class II small molecule synthesis, and class III macromolecule assembly. Differences between bacterial and human cells allow some class III reactions like peptidoglycan cell wall synthesis to be targeted.
Antibiotics are chemical substances that inhibit or kill microorganisms. They work by interfering with essential bacterial processes like cell wall synthesis, protein synthesis, and DNA replication. Common antibiotics target bacterial enzymes involved in these processes, disrupt bacterial cell membranes, or inhibit the formation of the bacterial ribosome. The document provides examples of several classes of antibiotics and how they exert their antibacterial effects.
- Antibiotics target specific bacterial processes like cell wall synthesis and protein translation that are absent in human cells, allowing selective toxicity. However, widespread antibiotic use creates selective pressure that leads to resistance through mutations or acquisition of resistance genes. Resistance occurs via target modification, decreased drug uptake, active drug export, or drug inactivation. Proper antibiotic usage is needed to reduce unnecessary selective pressure for resistance.
Antibiotic sensitivity and resistance .pptx seminar 2Dr. Mitali Thamke
This document discusses antibiotic sensitivity and resistance. It covers the historical development of antibiotics, classifications of antibiotics based on chemical structure and mechanism of action, and mechanisms of antibiotic resistance. Antibiotic resistance can occur via genetic or non-genetic means, including production of enzymes that break down antibiotics, modification of antibiotic targets, and changes to cell permeability. Testing methods like disc diffusion and dilution tests are used to determine antibiotic sensitivity.
This document discusses chemotherapy and antimicrobial agents. It begins by classifying microorganisms into bacteria, viruses, fungi and parasites. Antimicrobial agents are then classified based on the microorganism they target. Chemotherapy refers to using drugs that are selectively toxic to invading microorganisms. Antibiotics kill or inhibit the growth of microbes. The ideal antimicrobial exhibits selective toxicity against the pathogen without harming the host. Classification of antibiotics is based on their spectrum of activity and biochemical pathway targeted. The document then discusses the cell walls and structures of different microbes and how it impacts antimicrobial penetration. It also covers minimum inhibitory concentrations, post-antibiotic effects, bacterial growth cycles and methods for testing microbial susceptibility.
The document discusses antimicrobial agents and their properties and mechanisms of action. It defines antimicrobials as agents that kill or inhibit microorganisms with little host damage. Antimicrobials include antibiotics, which are low molecular substances produced by microorganisms that inhibit or kill other microorganisms. Antimicrobials act through various mechanisms including inhibiting cell wall synthesis, disrupting cell membranes, inhibiting protein synthesis, and interfering with nucleic acid synthesis. They can cause side effects like toxicity, allergies, and disruption of normal microflora. Microorganisms can develop resistance to antimicrobials through genetic or non-genetic changes.
Antimicrobial drugs work by killing or inhibiting the growth of microorganisms like bacteria, fungi, viruses, and parasites. They have a range of activity from those only effective against prokaryotic cells to those effective against eukaryotic pathogens. Their mechanisms of action include inhibiting cell wall, protein, or nucleic acid synthesis; damaging membranes; or blocking metabolic pathways. Examples are penicillin, which inhibits cell wall synthesis in bacteria, and quinolones, which interfere with bacterial DNA replication. Antimicrobial drugs must selectively target microbes without harming the host organism.
1. The document discusses the classification and mechanisms of action of various antibiotics. It begins by defining antibiotics and explaining their selective toxicity towards bacteria.
2. The document then covers various classifications of antibiotics including by chemical structure and mechanism of action. The main mechanisms discussed are inhibition of cell wall synthesis, protein synthesis, and DNA/RNA synthesis.
3. Specific antibiotic classes are then described in more detail, including beta-lactams, glycopeptides, macrolides, lincosamides, streptogramins, aminoglycosides, tetracyclines, oxazolidinones, quinolones, metronidazole, rifampin, sulfonamides, and tri
Bacteria have their own enzymes for
1. Cell wall formation
2. Protein synthesis
3. DNA replication
4. RNA synthesis
5. Synthesis of essential metabolites
Antibiotic resistance I Mechanism I Types I Contributing factors.kausarneha
Antibiotic resistance in bacteria is a global threat of 21st century. Here is a brief discussion of Antimicrobial resistance or Drug resistance disease. If you want to study via video lecture on this visit on my YouTube channel : Microbiology WISDOM:
Here you can find further more such interesting topics.
This document discusses antimicrobial drugs, including antibiotics. It defines antibiotics as substances produced by microorganisms that inhibit other microbes. It lists several antibiotic-producing microbes such as Bacillus, Penicillium, Streptomyces, and Micromonospora. The document also discusses the mechanisms of action of antimicrobials including inhibition of cell wall synthesis, protein synthesis, and nucleic acid synthesis. It provides examples of antimicrobials that act through these mechanisms like penicillin, tetracyclines, and rifampin. Finally, it notes some safety concerns with antimicrobial use like toxicity, interactions, resistance, and effects on normal flora.
Pharmacogenetics and antibiotic drugs.pptxGunjitSetia1
Antibiotics have revolutionized modern medicine, saving countless lives by combatting bacterial infections.
However, the emergence of antibiotic-resistant bacteria presents a formidable challenge to global health.
Pharmacogenetics focuses on the interplay between an individual's genetic makeup and their response to drugs.
This presentation delves into the intriguing realm of pharmacogenetics within the context of antibiotic therapy, aiming to shed light on how genetic variations can influence antibiotic effectiveness and how this knowledge can be harnessed to develop more precise, personalized treatment strategies.
Basic of Antibiotic.pptx , review of antibioticssengsong07072000
This document provides an overview of antibiotics, including their classification, mechanisms of action, pharmacokinetics, and contraindications. It begins with definitions of antibiotics and discusses how they were initially derived from bacteria. It then covers the classification of antibiotics based on their mode of action, chemical structure, spectrum of activity, and route of administration. The document also summarizes the fundamental principles of pharmacokinetics, including absorption, distribution, metabolism, and excretion of drugs. It briefly discusses the contraindications of antibiotics before concluding with the importance of understanding antibiotics to protect healthcare systems.
Lycopene is a carotenoid responsible for the red color of tomatoes. Research shows lycopene may help prevent certain cancers, as eating 7+ servings of raw tomatoes weekly was linked to a 60% lower risk of stomach, colon, or rectal cancer compared to 2 or fewer servings. Lycopene has antioxidant properties and inhibits the growth of cancer cells in vitro. Studies in animals also suggest lycopene may prevent cancers of the mammary gland, liver, skin, lungs and colon. When combined with S-allylcysteine from garlic, lycopene reduced chemically induced gastric cancer in rodents.
This document provides an introduction to chemotherapy and antibiotic mechanisms. It discusses the history of chemotherapy and defines it as treatment of infections or cancer selectively targeting pathogens or cancerous cells. The key differences between prokaryotic and eukaryotic cells allow for this selectivity. Antibiotics derived from microorganisms act by inhibiting cell wall synthesis, altering membranes, inhibiting protein synthesis, or suppressing DNA synthesis. Bacteria develop resistance via genetic mutations, plasmids transferring resistance genes, or biochemical mechanisms like deactivating the antibiotic or modifying its target. Proper dosing principles include achieving the minimum inhibitory concentration and considering the antibiotic's concentration-dependent killing, time-dependent killing, and post-antibiotic effect.
Similar to Antibiotics and Chemotherapeutic agents.pdf (20)
Osteoporosis - Definition , Evaluation and Management .pdfJim Jacob Roy
Osteoporosis is an increasing cause of morbidity among the elderly.
In this document , a brief outline of osteoporosis is given , including the risk factors of osteoporosis fractures , the indications for testing bone mineral density and the management of osteoporosis
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central19various
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Integrating Ayurveda into Parkinson’s Management: A Holistic ApproachAyurveda ForAll
Explore the benefits of combining Ayurveda with conventional Parkinson's treatments. Learn how a holistic approach can manage symptoms, enhance well-being, and balance body energies. Discover the steps to safely integrate Ayurvedic practices into your Parkinson’s care plan, including expert guidance on diet, herbal remedies, and lifestyle modifications.
Rasamanikya is a excellent preparation in the field of Rasashastra, it is used in various Kushtha Roga, Shwasa, Vicharchika, Bhagandara, Vatarakta, and Phiranga Roga. In this article Preparation& Comparative analytical profile for both Formulationon i.e Rasamanikya prepared by Kushmanda swarasa & Churnodhaka Shodita Haratala. The study aims to provide insights into the comparative efficacy and analytical aspects of these formulations for enhanced therapeutic outcomes.
share - Lions, tigers, AI and health misinformation, oh my!.pptxTina Purnat
• Pitfalls and pivots needed to use AI effectively in public health
• Evidence-based strategies to address health misinformation effectively
• Building trust with communities online and offline
• Equipping health professionals to address questions, concerns and health misinformation
• Assessing risk and mitigating harm from adverse health narratives in communities, health workforce and health system
Cell Therapy Expansion and Challenges in Autoimmune DiseaseHealth Advances
There is increasing confidence that cell therapies will soon play a role in the treatment of autoimmune disorders, but the extent of this impact remains to be seen. Early readouts on autologous CAR-Ts in lupus are encouraging, but manufacturing and cost limitations are likely to restrict access to highly refractory patients. Allogeneic CAR-Ts have the potential to broaden access to earlier lines of treatment due to their inherent cost benefits, however they will need to demonstrate comparable or improved efficacy to established modalities.
In addition to infrastructure and capacity constraints, CAR-Ts face a very different risk-benefit dynamic in autoimmune compared to oncology, highlighting the need for tolerable therapies with low adverse event risk. CAR-NK and Treg-based therapies are also being developed in certain autoimmune disorders and may demonstrate favorable safety profiles. Several novel non-cell therapies such as bispecific antibodies, nanobodies, and RNAi drugs, may also offer future alternative competitive solutions with variable value propositions.
Widespread adoption of cell therapies will not only require strong efficacy and safety data, but also adapted pricing and access strategies. At oncology-based price points, CAR-Ts are unlikely to achieve broad market access in autoimmune disorders, with eligible patient populations that are potentially orders of magnitude greater than the number of currently addressable cancer patients. Developers have made strides towards reducing cell therapy COGS while improving manufacturing efficiency, but payors will inevitably restrict access until more sustainable pricing is achieved.
Despite these headwinds, industry leaders and investors remain confident that cell therapies are poised to address significant unmet need in patients suffering from autoimmune disorders. However, the extent of this impact on the treatment landscape remains to be seen, as the industry rapidly approaches an inflection point.
Basavarajeeyam is a Sreshta Sangraha grantha (Compiled book ), written by Neelkanta kotturu Basavaraja Virachita. It contains 25 Prakaranas, First 24 Chapters related to Rogas& 25th to Rasadravyas.
3. Outline
i. Definations
ii. Differance between Antibiotics and Chemotherapeutic Agents
iii. Antibiotics
iv. Mode of action of Antibiotics
v. Chemotherapeutic Agents
4. Definations
• Antibiotics
Antibiotics are medicines that fight infections caused by bacteria in humans and animals by either killing the bacteria or making it
difficult for the bacteria to grow and multiply. Bacteria are germs. They live in the environment and all over the inside and outside
of our bodies.
• Chemotheraputic Agents
The treatment of a disease with a chemical substance is called chemotherapy and the chemical substance used for the purpose is
known as a chemotherapeutic drug/agent (generally called therapeutic drug/agent).
5. Differance between Antibodies and Chemotheraputic agents
• Chemotherapeutic agents commonly refer to drugs used in the treatment of cancer.
These drugs aim at destroying or controlling cancer cells by damaging DNA or
interfering with cell division and growth.
• In contrast, antibiotics are a group of drugs used to treat bacterial infections by
killing or inhibiting the growth of bacteria.
• Both groups relate to medical treatments but chemotherapeutics cater specifically to
attack malignant cells mostly attributed with cancers whilst antibacterial targets any
microorganisms causing problematic infections/diseases without discrimination.
• Chemotherapeutic agents and antibiotics can also be differentiate on the basis of:
i. Target cells
ii. Mechanism of action
iii. Toxicity
6. Antibiotics
• Sources of Antibiotics
i. Natural: mainly fungi sources e.g Benzylpenicillin.
ii. Semi-synthetic: chemically altered natural compund e.g Ampicillin.
iii. Synthetic: chemically designed in lab e.g Moxifloxacin.
• Role of Antibiotics
i. Bactericidal effect
ii. Bacteriostatic effect
7. Mode Of Action Of Antibiotics
• There are six major modes of
action:
1. Interference with cell wall synthesis
2. Inhibition of protein synthesis
3. Interference with nucleic acid synthesis
4. Inhibition of a metabolic pathway
5. Inhibition of membrane function
6. Inhibition of ATP Synthase
8. Conti.
1. Interference with cell wall synthesis
Bacterial cells are surrounded by cell walls made of peptidoglycan. Peptidoglycan biosynthesis is essential to the integrity of the cell wall
structure, and it is the outermost layer and the main component of the cell wall. Specific antibiotics interfere with the biosynthesis of
peptidoglycans, thereby destroying the integrity of the cell wall. Since mammalian cells do not have the peptidoglycan wall structure,
inhibition of cell wall peptidoglycan biosynthesis is a preferred target for the discovery of antibacterial agents, and at the same time has
no significant negative impact on mammalian host cells.
2. Inhibition of protein synthesis
Protein synthesis is a complex, multi-step process involving many enzymes and conformational alignment. However, most antibiotics interfere with the
30S or 50S subunits of the 70S bacterial ribosome to block bacterial protein synthesis. For example, tetracyclines, including doxycycline, prevent the
binding of aminoacyl-tRNA by blocking the A (aminoacyl) site of the 30S ribosome. They are capable of inhibiting protein synthesis in both 70S and
80S (eukaryotic) ribosomes.
3. Interference with nucleic acid synthesis
Antibiotics can inhibit replication, transcription, and folate synthesis of microorganisms. Quinolone drugs can interfere with DNA synthesis by
inhibiting topoisomerase, an enzyme involved in DNA replication. For example, the second-generation quinolone drugs levofloxacin, norfloxacin, and
ciprofloxacin are active against both Gram-negative and Gram-positive bacteria. There are also antibiotics that interfere with RNA synthesis by
inhibiting RNA polymerases, such as doxorubicin and actinomycin D (dactinomycin). They interfere with bacterial and mammalian systems and are
therefore most commonly used as antineoplastic and antitumor drugs, attacking rapidly growing malignant cells as well as normal cells.
9. Conti.
4. Inhibition of a metabolic pathway
Bacterial metabolism inhibitors are a class of antibiotics that target nucleic acid and amino acid synthesis pathways. Tetrahydro-folic Acid
(TH4) is a key coenzyme used to synthesize nucleic acids and certain amino acids in all life forms. Bacteria synthesize their folic acid
from the precursor para-aminobenzoic acid (PABA). Bacterial metabolism inhibitors affect bacterial metabolic pathways by interfering
with the bacterial TH4 synthesis.
5. Inhibition of membrane function
The bacterial membrane provides selective permeability for cellular homeostasis and metabolic energy-transduction. Several
antimicrobial agents interfere with multiple targets through the interaction of a lipophilic moiety with the bacterial membrane, leading to
the destruction of membrane structures and functional impairment. At present, antibacterial agents directed against the cytoplasmic
membrane components of bacteria have been reported, and they can act on both Gram-negative and Gram-positive bacteria.
6. Inhibition of ATP Synthase
ATP synthase is the principal energy-generating enzyme in all organisms from bacteria to vertebrates through oxidative phosphorylation
or photophosphorylation. Bacteria can produce ATP through substrate-level phosphorylation of fermentable carbon sources or oxidative
phosphorylation using respiratory chains and ATP synthase. Some antibiotics have been found to inhibit oxidative phosphorylation of ATP
synthase to affect the energy production of bacteria, which in turn kills bacteria.
10. Chemotherapeutic Agents
• Chemotherapeutic agents can be classified either by the
i. Effect of agents on the cell
ii. Pharmacological properties of the agent
• Chemotherapeutic agents can be divided into
i. Cell cycle-specific agents: These are agents effective at a specific phase (e.g S & M phase) in the cell cycle to prevent
cell replication by demaging cellular DNA and blocking production of protien important for RNA and DNA synthesis
ii. Cell cycle-non specific agents: These are the agents effective throughout all the phases of cell cycle, including the
resting phase.
• Chemotherapeutic agents on the basis of pharmacological
properties:
i. Alkylating agents
ii. Antimetabolites
iii. Antitumor antibodies
iv. Mitotic inhibitors
v. Hormones and hormone antagonists
vi. Miscellaneous agents
11. Alkylating agents
• Not a phase specific.
• Act on preformed nucleic acid by creating defects in tumor
DNA.
• Cause crosslinking of DNA strand and interfere with replication
and transcription
• Act with proliferating and non proliferating cells those in G0
phase.
12. Antimetabolites
• Phase specific.
• Work best in the S phase and having little effect in G0.
• Interefere with nucleic acid synthesis by displacing metabolities
at the regulatory site of key enzzyme.
13. Antitumor Antibodies
• Derived from natural sources that are generally too toxic to be
used as anti-bacterial agents
• Not phase specific
• Act in several ways:
-They disrupt DNA replication and RNA transcription
-Create free radicals which generate breaks in DNA
-Interfere with DNA repair
• These antibiotics include; Actinomycin-D, Mitomycin-C
14. Mitotic inhibitors
• Drugs that act to prevent cell division during the M phase.
• Include the plants alkaloids and taxoids
15. Hormones and Antagonists
• Main hormone used in cancer therapy are the corticosteroids
(phase specific).
• Act by binding to specific interacellular receptors, repressing
transcription of mRNA and thereby altering cellular function
and growth.
• Work with hormone binding tumors. They block hormon’s
receptor site on the tumor and prevent it from receiving normal
hormonal growth stimulation.
16. Miscellaneous Agents
• Act at different site in cell cycle;
-Cisplatin
-Carboplatin
-Mitotane
-Procarbazine